Price transparency and the future of healthcare markets | PwC's Next in Health
Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Director, James Lin, on price transparency regulations, including:
- Key implications and considerations for payers, providers and pharma and life sciences
- Impacts to consumer behavior and market pricing
- How to improve the relationship between price and quality transparency.
Speaker
Igor Belokrinitsky
Jenny Colapietro
James Lin
Company
Strategy&, PwC
PricewaterhouseCoopers
PricewaterhouseCoopers
Event Webpage (Available for subscribers only)
Category(s): Health Plans, Health Policy and Regulatory, Hospitals and Health Systems
Format
Podcast
Contact Speaker / Organization (Available for subscribers only)